Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function.

Source:http://linkedlifedata.com/resource/pubmed/id/18495876

J. Neurosci. 2008 May 21 28 21 5422-32

Download in:

View as

General Info

PMID
18495876